CIREX | CVLOX | CIREX / CVLOX | |
Total Expense Ratio | 0.85 | 1.22 | 70% |
Annual Report Gross Expense Ratio | 0.85 | 1.45 | 59% |
Fund Existence | 24 years | 29 years | - |
Gain YTD | 15.156 | 11.797 | 128% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 118B | 299M | 39,465% |
Annual Yield % from dividends | 2.69 | 0.53 | 509% |
Returns for 1 year | 11.63 | 6.74 | 172% |
Returns for 3 years | 39.47 | 47.33 | 83% |
Returns for 5 years | 53.56 | 33.47 | 160% |
Returns for 10 years | 90.32 | 68.72 | 131% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 37.99 | 0.91 | +2.44% |
Global X Genomics & Biotechnology ETF | |||
MQY | 11.19 | 0.15 | +1.36% |
Blackrock Muni Yield Quality Fund | |||
RSP | 188.44 | 0.22 | +0.12% |
Invesco S&P 500® Equal Weight ETF | |||
SIXD | 28.08 | N/A | -0.01% |
AllianzIM US Lrg Cp 6M Bfr10 Jun/Dec ETF | |||
CPER | 27.94 | -0.14 | -0.50% |
United States Copper Index |